力诺药包 - Financials

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
+Revenue	1.1B	947.0M	822.0M	889.0M	660.0M
Revenue Growth %	14.1%	15.2%	-7.5%	34.7%	--
Total Revenue	1.1B	947.0M	822.0M	889.0M	660.0M
Cost Of Revenue	875.0M	782.0M	640.0M	666.0M	491.0M
+Gross Profit	206.0M	165.0M	182.0M	223.0M	169.0M
Gross Margin %	19.1%	17.4%	22.1%	25.1%	25.6%
Total Operating Cost	1.0B	900.0M	720.0M	764.0M	569.0M
Selling Expenses	48.5M	39.5M	25.5M	23.1M	18.6M
Admin Expenses	38.5M	28.2M	24.8M	28.1M	25.0M
Rd Expenses	33.8M	30.1M	26.0M	32.5M	24.3M
Finance Expenses	17.3M	4.8M	-8.4M	2.2M	4.3M
+Operating Income	72.1M	72.9M	127.0M	140.0M	108.0M
Operating Margin %	6.7%	7.7%	15.5%	15.7%	16.4%
Non Operating Income	20,300	1,600	6,900	34,600	129,100
Non Operating Expenses	686,200	81,200	246,000	113,500	6.0M
Investment Income	11.8M	11.9M	12.9M	5.2M	4.7M
Fair Value Change Income	1.5M	2.2M	1.3M	--	--
Asset Disposal Income	20,900	46,100	465,500	446,200	543,800
Asset Impairment Loss	9.5M	5.6M	5.6M	2.7M	1.8M
Other Income	9.6M	11.1M	10.1M	9.4M	12.0M
Income Before Tax	71.4M	72.8M	127.0M	140.0M	102.0M
Income Tax	5.4M	6.9M	10.1M	15.5M	11.3M
+Net Income	66.1M	65.9M	117.0M	125.0M	90.8M
Net Margin %	6.1%	7.0%	14.2%	14.1%	13.8%
Net Income Attributable	66.1M	65.9M	117.0M	125.0M	90.8M
Eps Basic	0.29	0.28	0.50	0.70	0.52
Eps Diluted	0.29	0.30	0.50	0.70	0.52

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash And Equivalents	490.0M	447.0M	413.0M	711.0M	57.1M
Trading Financial Assets	296.0M	453.0M	117.0M	--	--
Accounts Receivable	208.0M	185.0M	146.0M	150.0M	105.0M
Notes Receivable	46.3M	29.0M	23.5M	14.6M	12.4M
Notes And Accounts Receivable	254.0M	214.0M	169.0M	164.0M	118.0M
Prepayments	17.2M	11.3M	16.6M	14.4M	8.7M
Inventory	273.0M	205.0M	165.0M	118.0M	101.0M
Total Current Assets	1.4B	1.4B	935.0M	1.0B	293.0M
Long Term Equity Investment	53.0M	48.7M	44.4M	39.3M	34.4M
Fixed Assets	--	612.0M	519.0M	335.0M	324.0M
Fixed Assets Total	667.0M	612.0M	519.0M	335.0M	324.0M
Construction In Progress	--	31.9M	72.9M	109.0M	3.5M
Construction In Progress Total	150.0M	31.9M	72.9M	109.0M	3.5M
Intangible Assets	70.3M	26.4M	27.4M	28.6M	29.1M
Long Term Deferred Expenses	1.5M	5.4M	4.9M	6.4M	8.4M
Total Non Current Assets	978.0M	795.0M	705.0M	539.0M	417.0M
Total Assets	2.4B	2.2B	1.6B	1.6B	710.0M
Short Term Borrowings	15.0M	--	--	25.0M	34.1M
Accounts Payable	183.0M	110.0M	135.0M	122.0M	59.9M
Advance Receipts	--	--	--	--	--
Contract Liabilities	14.3M	18.7M	16.1M	10.3M	9.6M
Total Current Liabilities	337.0M	192.0M	196.0M	190.0M	143.0M
Long Term Borrowings	--	--	--	--	--
Total Non Current Liabilities	465.0M	399.0M	12.8M	9.7M	15.2M
Total Liabilities	802.0M	591.0M	209.0M	200.0M	158.0M
Paid In Capital	232.0M	232.0M	232.0M	232.0M	174.0M
Capital Reserve	799.0M	798.0M	798.0M	798.0M	171.0M
Surplus Reserve	77.9M	71.3M	64.7M	53.0M	40.6M
Retained Earnings	386.0M	349.0M	336.0M	278.0M	165.0M
Equity Attributable	1.6B	1.6B	1.4B	1.4B	551.0M
Total Equity	1.6B	1.6B	1.4B	1.4B	551.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash From Sales	826.0M	783.0M	700.0M	703.0M	579.0M
Total Operating Cash Inflow	900.0M	804.0M	713.0M	725.0M	610.0M
Cash Paid For Goods	497.0M	545.0M	495.0M	478.0M	378.0M
Cash Paid To Employees	202.0M	158.0M	127.0M	134.0M	98.5M
Taxes Paid	18.7M	7.8M	22.5M	32.4M	16.3M
Total Operating Cash Outflow	777.0M	743.0M	667.0M	672.0M	522.0M
Operating Cash Flow	123.0M	61.4M	46.4M	52.5M	88.7M
Total Investing Cash Inflow	2.9B	857.0M	1.3B	367,200	43.8M
Total Investing Cash Outflow	3.0B	1.3B	1.6B	73.4M	96.2M
Investing Cash Flow	-68.2M	-472.0M	-301.0M	-73.0M	-52.4M
Cash From Borrowings	15.0M	491.0M	--	42.0M	49.3M
Dividends And Interest Paid	24.5M	46.5M	46.6M	1.5M	5.0M
Debt Repayments	--	--	25.0M	51.1M	68.8M
Total Financing Cash Inflow	15.0M	491.0M	--	749.0M	49.3M
Total Financing Cash Outflow	74.5M	49.6M	75.8M	68.9M	82.9M
Financing Cash Flow	-59.5M	442.0M	-75.8M	680.0M	-33.6M
Net Change In Cash	-2.6M	31.5M	-331.0M	660.0M	2.7M
Ending Cash Balance	401.0M	403.0M	372.0M	703.0M	43.0M
Capex	210.0M	113.0M	162.0M	73.4M	75.2M